Wave Life Sciences director Adrian Rawcliffe sells 12,700 shares for $67,183
Reuters2026/08/14 01:00- Wave Life Sciences Ltd. director Adrian Rawcliffe sold 12,700 common shares on Aug. 12, 2026.
- Shares sold at a weighted-average price of $5.29.
- Rawcliffe reported 0 shares owned following the transaction.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ivy League’s space gamble: Harvard reveals $2.2 billions SpaceX position, its largest single stock holding
Harvard University Investment Management Company disclosed that it holds $2.2 billion worth of SpaceX shares, making it the largest single stock position in its $4.3 billion US equity portfolio. This holding originated from Harvard’s early investment in SpaceX through venture capital funds, and the position has significantly appreciated after SpaceX’s public listing in June this year. The University of California also disclosed a roughly $1 billion position in SpaceX during the same period. Over the past decade, endowment funds from several universities have made substantial bets on private tech assets.
Circle obtains Major Payment Institution license in Singapore
Crypto prices
More
